Literature DB >> 24964786

The effect of fibrin(ogen) on thrombin generation and decay.

R M W Kremers1, R J Wagenvoord, H C Hemker.   

Abstract

Defibrination causes a ~30% decrease of thrombin generation (TG) which can be restored by adding native fibrinogen in its original concentration (3 mg/ml). The fibrinogen variant γA/γ', which binds thrombin with high affinity, is over four times more efficient in this respect than the more common γA/γA form. By using high tissue factor concentrations we accelerated prothrombin conversion so as to obtain a descending part of the TG curve that was governed by thrombin decay only. From that part we calculated the antithrombin (AT)- and α2-macroglobulin-dependent decay constants at a series of concentrations of native, γA/γA and γA/γ' fibrinogen. We found that the increase of TG in the presence of fibrinogen is primarily due to a dose-dependent decrease of thrombin inactivation by α2-macroglobulin, where the γA/γ' form is much more active than the γA/γA form. AT-dependent decay is somewhat decreased by γA/γ' fibrinogen but hardly by the γA/γA form. We assume that binding of thrombin to fibrin(ogen) interferes with its binding to inhibitors. Attenuation of decay only in part explains the stimulating effect of fibrinogen on TG, as fibrinogen stimulates prothrombin conversion, regardless of the fibrinogen variant.

Entities:  

Keywords:  Fibrinogen; gamma chain; prothrombin conversion; thrombin decay; thrombin generation

Mesh:

Substances:

Year:  2014        PMID: 24964786     DOI: 10.1160/TH14-02-0172

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  High fibrinogen γ' levels in patient plasma increase clot formation at arterial and venous shear.

Authors:  Fraser L Macrae; Frauke Swieringa; Johan W M Heemskerk; Robert A S Ariëns
Journal:  Blood Adv       Date:  2021-09-14

2.  Increased BMI and Blood Lipids Are Associated With a Hypercoagulable State in the Moli-sani Cohort.

Authors:  Romy de Laat-Kremers; Augusto Di Castelnuovo; Lisa van der Vorm; Simona Costanzo; Marisa Ninivaggi; Chiara Cerletti; Dana Huskens; Amalia De Curtis; Alessandro Gialluisi; Cuicui Bai; Giovanni de Gaetano; Dongmei Yin; Maria Benedetta Donati; Bas de Laat; Licia Iacoviello
Journal:  Front Cardiovasc Med       Date:  2022-06-16

3.  γ' fibrinogen levels are associated with blood clot strength in traumatic brain injury patients.

Authors:  David H Farrell; Elizabeth A Rick; Elizabeth N Dewey; Martin A Schreiber; Susan E Rowell
Journal:  Am J Surg       Date:  2019-12-28       Impact factor: 2.565

4.  Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.

Authors:  Romy M W Kremers; Marie-Claire Kleinegris; Marisa Ninivaggi; Bas de Laat; Hugo Ten Cate; Ger H Koek; Rob J Wagenvoord; H Coenraad Hemker
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

5.  Fibrinography: A Multiwavelength Light-Scattering Assay of Fibrin Structure.

Authors:  Carhel Dassi; Landry Seyve; Xabel García; Emmanuelle Bigo; Raphaël Marlu; François Caton; Benoît Polack
Journal:  Hemasphere       Date:  2019-01-24

6.  ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.

Authors:  Marisa Ninivaggi; Romy M W de Laat-Kremers; Audrey Carlo; Bas de Laat
Journal:  Res Pract Thromb Haemost       Date:  2020-12-19

7.  Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay.

Authors:  Audrey Carlo; Qiuting Yan; Hugo Ten Cate; Romy De Laat-Kremers; Bas De Laat; Marisa Ninivaggi
Journal:  Front Cardiovasc Med       Date:  2022-07-26

8.  Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S.

Authors:  Bas de Laat; Hendrik Stragier; Romy de Laat-Kremers; Marisa Ninivaggi; Dieter Mesotten; Steven Thiessen; Kristien Van Pelt; Mark Roest; Joris Penders; Pascal Vanelderen; Dana Huskens; Raf De Jongh; Margot Vander Laenen; Tom Fivez; Hugo Ten Cate; Rene Heylen; Line Heylen; Deborah Steensels
Journal:  Front Cardiovasc Med       Date:  2022-07-29

Review 9.  Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis.

Authors:  Anne-Marije Hulshof; H Coenraad Hemker; Henri M H Spronk; Yvonne M C Henskens; Hugo Ten Cate
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.